Tissue Dynamics

Tissue Dynamics is a biotechnology company focused on developing innovative therapeutics for cardiovascular and metabolic diseases. By exploring the underlying mechanisms of human metabolism, it creates first-in-class treatments aimed at countering age-related declines in metabolic function.

ImpriMed

ImpriMed uses artificial intelligence to predict the effectiveness of anticancer drugs for dogs with lymphoma or leukemia. By analyzing live cancer cells, they provide personalized treatment options, helping veterinarians choose the most effective chemotherapy for each dog.

Insilico Medicine

Insilico Medicine is a biotechnology company that leverages artificial intelligence to revolutionize drug discovery and development. The company focuses on using advanced machine learning techniques to accelerate the process of identifying new drug targets, designing novel molecules, and optimizing clinical trials. 

Absci

Absci is a biotechnology company that uses artificial intelligence to revolutionize the process of creating new biologic drugs. They specialize in designing antibodies from scratch using computer algorithms, bypassing traditional methods that rely on existing antibody libraries. Absci’s platform combines AI-driven design with rapid experimental validation to significantly reduce the time and cost typically associated with bringing new drug candidates to clinical trials.

Evaxion Biotech

Evaxion Biotech is a biotechnology company that specializes in developing vaccines using artificial intelligence. Their proprietary AI platform is designed to identify potential vaccine targets for both cancer and infectious diseases.

Envisagenics

Envisagenics is an AI-driven biotechnology company that specializes in RNA splicing research and therapeutic development. They use their proprietary platform, which combines artificial intelligence and machine learning, to analyze RNA sequencing data and identify novel RNA splicing variants associated with diseases.

AcuraStem

AcuraStem is a biotechnology company focused on developing innovative treatments for neurodegenerative diseases, including ALS and frontotemporal dementia. Utilizing its proprietary iNeuroRx® platform, AcuraStem creates patient-derived disease models that accurately reflect the complexities of these conditions. By integrating advanced AI techniques, the company aims to identify effective therapeutics tailored to individual patient needs, enhancing the potential for successful treatment outcomes in neurodegeneration.

PrecisionLife

PrecisionLife is a precision medicine company that uses advanced analytics and AI to uncover disease mechanisms in complex chronic conditions. They identify patient subgroups, discover novel drug targets, and develop personalized treatments.

Recursion Pharmaceuticals

Recursion Pharmaceuticals is a biotechnology company that combines advanced technology with biological research to develop new medicines. They use large datasets of biological information, which they analyze using powerful computers and artificial intelligence.